Insights

Gathering insights about Bolt…

Similar companies to Bolt

Bolt Tech Stack

Bolt uses 8 technology products and services including AppNexus, Visual Website Optimizer, Google Font API, and more. Explore Bolt's tech stack below.

AppNexus
Advertising
Visual Website Optimizer
Analytics
Google Font API
Font Scripts
React
Javascript Frameworks
Vercel
Platform As A Service
Cloudflare Bot Management
Security
Vimeo
Video Players
Facebook
Widgets

Media & News

CSE Bulletin: Stock Split - Bolt Metals Corp. (BOLT)
Toronto, Ontario--(Newsfile Corp. - Le 11 novembre/November 2024) - Bolt Metals Corp. has announced a two (2) for one (1) stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive one (1) additional share for each share held on such date.
Nov 11, 2024 | www.newsfilecorp.com
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from BDC-1001 data suggest Boltbody™ ISACs with enhanced immune activation could offer greater efficacy, warranting further testing REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today presented updated preclinical data for BDC-4182, a next-generation Boltbody™ ISAC clinical candidate targeting claudin 18.2, and provided key learnings from its Phase 1 dose-escalation trial of BDC-1001 at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held in Houston, Texas from November 6-10, 2024.
Nov 07, 2024 | www.globenewswire.com
Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 06, 2024 | www.accesswire.com
The Schall Law Firm Invites Investors To Contribute To A Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 05, 2024 | www.accesswire.com
Bolt Biotherapeutics Announces Changes to its Board of Directors
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Jakob Dupont, M.D., to its Board of Directors. Dr. Dupont brings more than two decades of experience in the field of oncology and immuno-oncology. With the appointment of Dr. Dupont, Executive Partner at Sofinnova Investments, Dr. Jim Healy, M.D., Ph.D., also at Sofinnova, will be stepping down as Lead Independent Director. In addition, Frank D. Lee will be departing the Board and Brian O'Callaghan, CEO of Deep Genomics, will be assuming the role of Chair.
Sep 04, 2024 | www.globenewswire.com
Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 04, 2024 | www.accesswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT
NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ: BOLT) and certain officers.
Sep 03, 2024 | www.prnewswire.com

Bolt's Email Address Formats

Bolt uses at least 1 format(s):

Bolt Email Formats	Example	Percentage
First@boltenergie.be	John@boltenergie.be	50%
First@boltenergie.be	John@boltenergie.be	50%

Frequently Asked Questions

Where is Bolt's headquarters located?

Bolt's main headquarters is located at Sint-Lazaruslaan 4 Sint-Joost-ten-Node, Brussels Hoofdstedelijk Gewest 1210 BE. The company has employees across 5 continents, including EuropeAfricaAsia.

What is Bolt's stock symbol?

Bolt is a publicly traded company; the company's stock symbol is BOLT.

What is Bolt's official website and social media links?

Bolt's official website is boltenergie.be and has social profiles on LinkedIn.

How much revenue does Bolt generate?

As of December 2024, Bolt's annual revenue reached $3.8M.

What is Bolt's NAICS code?

Bolt's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Bolt have currently?

As of December 2024, Bolt has approximately 67 employees across 5 continents, including EuropeAfricaAsia. Key team members include Head Of Marketing: T. H.Head Of Sales: R. V. B.Co-Founder & Ceo: P. V.. Explore Bolt's employee directory with LeadIQ.

What industry does Bolt belong to?

Bolt operates in the IT Services and IT Consulting industry.

What technology does Bolt use?

Bolt's tech stack includes AppNexusVisual Website OptimizerGoogle Font APIReactVercelCloudflare Bot ManagementVimeoFacebook.

What is Bolt's email format?

Bolt's email format typically follows the pattern of . Find more Bolt email formats with LeadIQ.

When was Bolt founded?

Bolt was founded in 2018.

Bolt

IT Services and IT ConsultingBrussels Hoofdstedelijk Gewest, Belgium51-200 Employees

Bolt is the first online energy platform in Belgium that makes it possible and easy to choose your local, green energy producer yourself.

Company Overview

Headquarters: Sint-Lazaruslaan 4 Sint-Joost-ten-Node, Brussels Hoofdstedelijk Gewest 1210 BE
Website: boltenergie.be
Stock Symbol: BOLT
NAICS Code: 5415 - Computer Systems Design and Related Services
Founded: 2018
Employees: 51-200

Media & News

Funding & Financials

$10M
Bolt's revenue is in the range of $10M

Funding & Financials

$10M
Bolt's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Bolt

DiDi

Gojek

Lyft

Careem

Cabify

Grab

Ola

Taxify

Uber

Gett

Bolt Tech Stack

Media & News

CSE Bulletin: Stock Split - Bolt Metals Corp. (BOLT)

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

The Schall Law Firm Invites Investors To Contribute To A Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT

Bolt's Email Address Formats

Frequently Asked Questions

Where is Bolt's headquarters located?

What is Bolt's stock symbol?

What is Bolt's official website and social media links?

How much revenue does Bolt generate?

What is Bolt's NAICS code?

How many employees does Bolt have currently?

What industry does Bolt belong to?

What technology does Bolt use?

What is Bolt's email format?

When was Bolt founded?

Bolt

Company Overview

Media & News

CSE Bulletin: Stock Split - Bolt Metals Corp. (BOLT)

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?